220 related articles for article (PubMed ID: 33939331)
21. Opposing Roles of Wnt Inhibitors IGFBP-4 and Dkk1 in Cardiac Ischemia by Differential Targeting of LRP5/6 and β-catenin.
Wo D; Peng J; Ren DN; Qiu L; Chen J; Zhu Y; Yan Y; Yan H; Wu J; Ma E; Zhong TP; Chen Y; Liu Z; Liu S; Ao L; Liu Z; Jiang C; Peng J; Zou Y; Qian Q; Zhu W
Circulation; 2016 Dec; 134(24):1991-2007. PubMed ID: 27803037
[TBL] [Abstract][Full Text] [Related]
22. Atypical femoral fracture in osteoporosis pseudoglioma syndrome associated with two novel compound heterozygous mutations in LRP5.
Alonso N; Soares DC; V McCloskey E; Summers GD; Ralston SH; Gregson CL
J Bone Miner Res; 2015 Apr; 30(4):615-20. PubMed ID: 25384351
[TBL] [Abstract][Full Text] [Related]
23. Role of Sost in Wnt signal pathway in osteoporosis rats and regulating effect of soybean isoflavones on Wnt signal pathway.
Liang HD; Yu F; Lv P; Zhao ZN; Tong ZH
Mol Biol Rep; 2014 Jul; 41(7):4447-54. PubMed ID: 24760368
[TBL] [Abstract][Full Text] [Related]
24. High Bone Mass-Causing Mutant LRP5 Receptors Are Resistant to Endogenous Inhibitors In Vivo.
Niziolek PJ; MacDonald BT; Kedlaya R; Zhang M; Bellido T; He X; Warman ML; Robling AG
J Bone Miner Res; 2015 Oct; 30(10):1822-30. PubMed ID: 25808845
[TBL] [Abstract][Full Text] [Related]
25. Osteoporosis-pseudoglioma syndrome: clinical, genetic, and treatment-response study of 10 new cases in Greece.
Papadopoulos I; Bountouvi E; Attilakos A; Gole E; Dinopoulos A; Peppa M; Nikolaidou P; Papadopoulou A
Eur J Pediatr; 2019 Mar; 178(3):323-329. PubMed ID: 30499050
[TBL] [Abstract][Full Text] [Related]
26. Genetic analysis of high bone mass cases from the BARCOS cohort of Spanish postmenopausal women.
Sarrión P; Mellibovsky L; Urreizti R; Civit S; Cols N; García-Giralt N; Yoskovitz G; Aranguren A; Malouf J; Di Gregorio S; Río LD; Güerri R; Nogués X; Díez-Pérez A; Grinberg D; Balcells S
PLoS One; 2014; 9(4):e94607. PubMed ID: 24736728
[TBL] [Abstract][Full Text] [Related]
27. Pregnancy-associated osteoporosis with a heterozygous deactivating LDL receptor-related protein 5 (LRP5) mutation and a homozygous methylenetetrahydrofolate reductase (MTHFR) polymorphism.
Cook FJ; Mumm S; Whyte MP; Wenkert D
J Bone Miner Res; 2014 Apr; 29(4):922-8. PubMed ID: 24014470
[TBL] [Abstract][Full Text] [Related]
28. Pathogenic mutations and polymorphisms in the lipoprotein receptor-related protein 5 reveal a new biological pathway for the control of bone mass.
Ferrari SL; Deutsch S; Antonarakis SE
Curr Opin Lipidol; 2005 Apr; 16(2):207-14. PubMed ID: 15767861
[TBL] [Abstract][Full Text] [Related]
29. Low density lipoprotein receptor-related protein 5 gene polymorphisms and osteoporosis in Thai menopausal women.
Kitjaroentham A; Hananantachai H; Phonrat B; Preutthipan S; Tungtrongchitr R
J Negat Results Biomed; 2016 Sep; 15(1):16. PubMed ID: 27582019
[TBL] [Abstract][Full Text] [Related]
30. Serum levels of sclerostin, Dickkopf-1, and secreted frizzled-related protein-4 are not changed in individuals with high bone mass causing mutations in LRP5.
Simpson CA; Foer D; Lee GS; Bihuniak J; Sun B; Sullivan R; Belsky J; Insogna KL
Osteoporos Int; 2014 Oct; 25(10):2383-8. PubMed ID: 24927689
[TBL] [Abstract][Full Text] [Related]
31. Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling.
Ai M; Holmen SL; Van Hul W; Williams BO; Warman ML
Mol Cell Biol; 2005 Jun; 25(12):4946-55. PubMed ID: 15923613
[TBL] [Abstract][Full Text] [Related]
32. Analysis of association of LRP5, LRP6, SOST, DKK1, and CTNNB1 genes with bone mineral density in a Slovenian population.
Mencej-Bedrac S; Prezelj J; Kocjan T; Komadina R; Marc J
Calcif Tissue Int; 2009 Dec; 85(6):501-6. PubMed ID: 19898734
[TBL] [Abstract][Full Text] [Related]
33. Polymorphism of LRP5 gene and emphysema severity are associated with osteoporosis in Japanese patients with or at risk for COPD.
Chubachi S; Nakamura H; Sasaki M; Haraguchi M; Miyazaki M; Takahashi S; Tanaka K; Funatsu Y; Asano K; Betsuyaku T;
Respirology; 2015 Feb; 20(2):286-95. PubMed ID: 25392953
[TBL] [Abstract][Full Text] [Related]
34. Clinical and molecular findings in osteoporosis-pseudoglioma syndrome.
Ai M; Heeger S; Bartels CF; Schelling DK;
Am J Hum Genet; 2005 Nov; 77(5):741-53. PubMed ID: 16252235
[TBL] [Abstract][Full Text] [Related]
35. Reduced bone mineral density and hyaloid vasculature remnants in a consanguineous recessive FEVR family with a mutation in LRP5.
Downey LM; Bottomley HM; Sheridan E; Ahmed M; Gilmour DF; Inglehearn CF; Reddy A; Agrawal A; Bradbury J; Toomes C
Br J Ophthalmol; 2006 Sep; 90(9):1163-7. PubMed ID: 16929062
[TBL] [Abstract][Full Text] [Related]
36. Strong effect of SNP rs4988300 of the LRP5 gene on bone phenotype of Caucasian postmenopausal women.
Horváth P; Balla B; Kósa JP; Tóbiás B; Szili B; Kirschner G; Győri G; Kató K; Lakatos P; Takács I
J Bone Miner Metab; 2016 Jan; 34(1):79-85. PubMed ID: 25762437
[TBL] [Abstract][Full Text] [Related]
37. Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture.
Estrada K; Styrkarsdottir U; Evangelou E; Hsu YH; Duncan EL; Ntzani EE; Oei L; Albagha OM; Amin N; Kemp JP; Koller DL; Li G; Liu CT; Minster RL; Moayyeri A; Vandenput L; Willner D; Xiao SM; Yerges-Armstrong LM; Zheng HF; Alonso N; Eriksson J; Kammerer CM; Kaptoge SK; Leo PJ; Thorleifsson G; Wilson SG; Wilson JF; Aalto V; Alen M; Aragaki AK; Aspelund T; Center JR; Dailiana Z; Duggan DJ; Garcia M; Garcia-Giralt N; Giroux S; Hallmans G; Hocking LJ; Husted LB; Jameson KA; Khusainova R; Kim GS; Kooperberg C; Koromila T; Kruk M; Laaksonen M; Lacroix AZ; Lee SH; Leung PC; Lewis JR; Masi L; Mencej-Bedrac S; Nguyen TV; Nogues X; Patel MS; Prezelj J; Rose LM; Scollen S; Siggeirsdottir K; Smith AV; Svensson O; Trompet S; Trummer O; van Schoor NM; Woo J; Zhu K; Balcells S; Brandi ML; Buckley BM; Cheng S; Christiansen C; Cooper C; Dedoussis G; Ford I; Frost M; Goltzman D; González-Macías J; Kähönen M; Karlsson M; Khusnutdinova E; Koh JM; Kollia P; Langdahl BL; Leslie WD; Lips P; Ljunggren Ö; Lorenc RS; Marc J; Mellström D; Obermayer-Pietsch B; Olmos JM; Pettersson-Kymmer U; Reid DM; Riancho JA; Ridker PM; Rousseau F; Slagboom PE; Tang NL; Urreizti R; Van Hul W; Viikari J; Zarrabeitia MT; Aulchenko YS; Castano-Betancourt M; Grundberg E; Herrera L; Ingvarsson T; Johannsdottir H; Kwan T; Li R; Luben R; Medina-Gómez C; Palsson ST; Reppe S; Rotter JI; Sigurdsson G; van Meurs JB; Verlaan D; Williams FM; Wood AR; Zhou Y; Gautvik KM; Pastinen T; Raychaudhuri S; Cauley JA; Chasman DI; Clark GR; Cummings SR; Danoy P; Dennison EM; Eastell R; Eisman JA; Gudnason V; Hofman A; Jackson RD; Jones G; Jukema JW; Khaw KT; Lehtimäki T; Liu Y; Lorentzon M; McCloskey E; Mitchell BD; Nandakumar K; Nicholson GC; Oostra BA; Peacock M; Pols HA; Prince RL; Raitakari O; Reid IR; Robbins J; Sambrook PN; Sham PC; Shuldiner AR; Tylavsky FA; van Duijn CM; Wareham NJ; Cupples LA; Econs MJ; Evans DM; Harris TB; Kung AW; Psaty BM; Reeve J; Spector TD; Streeten EA; Zillikens MC; Thorsteinsdottir U; Ohlsson C; Karasik D; Richards JB; Brown MA; Stefansson K; Uitterlinden AG; Ralston SH; Ioannidis JP; Kiel DP; Rivadeneira F
Nat Genet; 2012 Apr; 44(5):491-501. PubMed ID: 22504420
[TBL] [Abstract][Full Text] [Related]
38. Common polymorphism in the LRP5 gene may increase the risk of bone fracture and osteoporosis.
Xu GY; Qiu Y; Mao HJ
Biomed Res Int; 2014; 2014():290531. PubMed ID: 25580429
[TBL] [Abstract][Full Text] [Related]
39. The importance of the Wnt/β-catenin pathway and LRP5 protein in bone metabolism of postmenopausal women.
Kamiński A; Karasiewicz M; Bogacz A; Dziekan K; Seremak-Mrozikiewicz A; Czerny B
Adv Clin Exp Med; 2019 Feb; 28(2):179-184. PubMed ID: 29963786
[TBL] [Abstract][Full Text] [Related]
40. Associations of LRP5 Gene With Bone Mineral Density, Bone Turnover Markers, and Fractures in the Elderly With Osteoporosis.
Wang QF; Bi HS; Qin ZL; Wang P; Nie FF; Zhang GW
Front Endocrinol (Lausanne); 2020; 11():571549. PubMed ID: 33101205
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
